DE60239622D1 - Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel - Google Patents

Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel

Info

Publication number
DE60239622D1
DE60239622D1 DE60239622T DE60239622T DE60239622D1 DE 60239622 D1 DE60239622 D1 DE 60239622D1 DE 60239622 T DE60239622 T DE 60239622T DE 60239622 T DE60239622 T DE 60239622T DE 60239622 D1 DE60239622 D1 DE 60239622D1
Authority
DE
Germany
Prior art keywords
monitoring
substitute
diagnosis
sugar change
gbp28
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239622T
Other languages
English (en)
Inventor
Motowo Tomita
Yasuko Nakano
Hiroshi Hirose
Koichi Matsubara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Application granted granted Critical
Publication of DE60239622D1 publication Critical patent/DE60239622D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
DE60239622T 2001-08-17 2002-08-16 Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel Expired - Lifetime DE60239622D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001248047 2001-08-17
PCT/JP2002/008331 WO2003016906A1 (fr) 2001-08-17 2002-08-16 Procede de diagnostic ou de controle d'une erreur du metabolisme du saccharose

Publications (1)

Publication Number Publication Date
DE60239622D1 true DE60239622D1 (de) 2011-05-12

Family

ID=19077272

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239622T Expired - Lifetime DE60239622D1 (de) 2001-08-17 2002-08-16 Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel

Country Status (10)

Country Link
US (2) US7067634B2 (de)
EP (1) EP1426764B1 (de)
JP (1) JP3624216B2 (de)
AT (1) ATE504001T1 (de)
AU (1) AU2002328630B2 (de)
CA (1) CA2459489C (de)
DE (1) DE60239622D1 (de)
DK (1) DK1426764T3 (de)
ES (1) ES2361663T3 (de)
WO (1) WO2003016906A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1607742B1 (de) 2003-03-24 2011-11-23 Mitsubishi Chemical Medience Corporation Latex-reaktionsmittel zur adiponectinanalyse und verfahren zur adiponectinanalyse
WO2004096272A2 (en) * 2003-04-29 2004-11-11 Cytos Biotechnology Ag Methods and compositions for modulating the interaction between adiponectin and its receptor
EP1718327B1 (de) 2003-06-20 2015-01-07 University of Florida Biomarker zur differenzierung zwischen typ-1- und typ-2-diabetes
US7176292B2 (en) * 2003-09-11 2007-02-13 Dialean, Ltd. Ghrelin variant protein
US7781171B2 (en) 2003-10-15 2010-08-24 Daiichi Pure Chemicals Co., Ltd. Mehod of pretreating sample and immunological assay method using the same
MXPA06004235A (es) * 2003-10-15 2007-02-14 Daiichi Pure Chemicals Co Ltd Metodo de separar y ensayar multimero de adiponectina.
JP4397934B2 (ja) 2003-11-07 2010-01-13 メルク エンド カムパニー インコーポレーテッド インスリン感作薬での処置に対する反応者を識別する方法
WO2005092367A1 (ja) * 2004-03-29 2005-10-06 Fuji Oil Company, Limited アディポネクチン分泌促進組成物
ATE515699T1 (de) 2004-03-31 2011-07-15 Kazuhisa Maeda Verwendung von adiponectin als marker in der vorhersage post-operativer infektion
WO2006084041A2 (en) 2005-02-02 2006-08-10 Mitos Pharmaceuticals, Inc. Nitroxides for use in treating or preventing diabetes
GB0617429D0 (en) * 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
US8017573B2 (en) * 2007-11-30 2011-09-13 Siemens Healthcare Diagnostics Inc. Adiponectin receptor fragments and methods of use
WO2010123720A1 (en) 2009-04-23 2010-10-28 Siemens Healthcare Diagnostics Inc. Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
WO2010128657A1 (ja) 2009-05-07 2010-11-11 三菱化学メディエンス株式会社 高分子アディポネクチン分析のための新規モノクローナル抗体とその利用
JP5048100B2 (ja) 2010-04-28 2012-10-17 シャープ株式会社 アディポネクチンに対する結合性を有するペプチド、ならびに該ペプチドを用いた分析方法および分析装置
RU2553943C1 (ru) * 2014-05-27 2015-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО МГМУ им. И.М. Сеченова) Способ диагностики инсулинорезистентности

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2285786T3 (es) 1997-10-29 2007-11-16 Otsuka Pharmaceutical Co., Ltd. Composiciones que inhiben la proliferacion de musculo liso y procedimiento para el diagnostico de arteriosclerosis.
WO2001032868A1 (en) * 1999-11-04 2001-05-10 Genset Apm1 biallelic markers and uses thereof

Also Published As

Publication number Publication date
ES2361663T3 (es) 2011-06-21
EP1426764A4 (de) 2005-12-14
US7435551B2 (en) 2008-10-14
JPWO2003016906A1 (ja) 2004-12-02
US7067634B2 (en) 2006-06-27
ATE504001T1 (de) 2011-04-15
AU2002328630B2 (en) 2005-09-01
US20050266506A1 (en) 2005-12-01
DK1426764T3 (da) 2011-06-27
US20050048565A1 (en) 2005-03-03
WO2003016906A1 (fr) 2003-02-27
EP1426764B1 (de) 2011-03-30
EP1426764A1 (de) 2004-06-09
JP3624216B2 (ja) 2005-03-02
CA2459489C (en) 2010-02-02
CA2459489A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
DE60239622D1 (de) Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel
EP2124053A1 (de) Verfahren und Gerät zur Erfassung biologischer Informationen und Verfahren und Gerät zur Messung physiologisch aktiver Substanzen
JP7269182B2 (ja) 心臓トロポニンｉ及び早期バイオマーカーを使用する、ヒト対象における軽度外傷性脳損傷を診断及び査定する一助となるための方法
ES2474690T3 (es) Indicador de carga biológica y método de medida de la carga biológica
CN110892266A (zh) 使用gfap和uch-l1的组合辅助诊断和评价人类受试者中创伤性脑损伤的方法
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
AU2018272054A1 (en) Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
DK1342794T3 (da) Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
CN110603449A (zh) 用同一人受试者的至少两种样品的早期生物标记物帮助超急性诊断确定创伤性脑损伤的方法
HK1113160A1 (en) Methods for the diagnosis of dementia and other neurological disorders
WO2005108989A3 (en) Assay for antibodies
WO2009132058A3 (en) Levels of bcma protein expression on b cells and use in diagnostic methods
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
WO2018175942A1 (en) Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
WO2008019695A3 (en) An interactive testing system for analysing biological samples.
TW200716981A (en) Method for the quantitative measurement of analytes in a liquid sample by immunochromatography
WO2010132447A3 (en) Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
US20190041407A1 (en) Devices, systems and methods for quantifying hemoglobin s concentration
EP1898215A4 (de) Verfahren zum testen endokriner substanz in proben
ATE520033T1 (de) Neurotoxische aminosäure oder neurotoxisches derivat davon in zusammenhang mit neurologischen erkrankungen
EP1560025A3 (de) Marker spezifisch für Diabetes
WO2016081453A1 (en) Lateral flow assay ratio test
EP3649474A1 (de) Verbesserte verfahren zur messung von ubiquitin-carboxy-terminalen hydrolase-l1-konzentrationen in blut
WO2008035204A3 (en) Prediction and prophylactic treatment of type 1 diabetes